203 related articles for article (PubMed ID: 1719729)
21. [Hemodilution, hemorheology and oxygen supply].
Ehrly AM
Acta Med Austriaca; 1991; 18 Suppl 1():3-8. PubMed ID: 1950386
[TBL] [Abstract][Full Text] [Related]
22. [Treadmill ergometer multistage test: a new alternative in diagnosis and therapeutic control of peripheral arterial occlusive disease].
Weidinger P; Bachl N; Liebenberger S
Vasa Suppl; 1988; 26():48-50. PubMed ID: 2462285
[No Abstract] [Full Text] [Related]
23. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
24. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
[TBL] [Abstract][Full Text] [Related]
25. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
[TBL] [Abstract][Full Text] [Related]
26. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
[TBL] [Abstract][Full Text] [Related]
27. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
Wohlleben E; Wohlleben H; Voigt H; Köhler H
Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
[TBL] [Abstract][Full Text] [Related]
28. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
[No Abstract] [Full Text] [Related]
29. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the effectiveness of physical training with parenteral drug therapy in Fontaine stage IIb peripheral arterial occlusive disease].
Streminski JA; de la Haye R; Rettig K; Kuntz G
Vasa; 1992; 21(4):392-402. PubMed ID: 1485475
[TBL] [Abstract][Full Text] [Related]
31. [Determination of plasma atrial natriuretic peptide in follow-up of hypervolemic hemodilution in patients with retinal circulatory disorders].
Wambach G; Voskuhl G; Paulmann H
Klin Monbl Augenheilkd; 1991 Aug; 199(2):99-102. PubMed ID: 1720475
[TBL] [Abstract][Full Text] [Related]
32. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
[TBL] [Abstract][Full Text] [Related]
33. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
[No Abstract] [Full Text] [Related]
34. [Autotransfusion with leap-frog technique in patients with coronary heart disease and planned aortocoronary venous bypass].
Kiesewetter H; Jung F; Pindur G; Koscielny J; Jakobs K; Wenzel E
Infusionsther Transfusionsmed; 1994 Apr; 21(2):96-103. PubMed ID: 7517239
[TBL] [Abstract][Full Text] [Related]
35. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
36. [Vagal stimulation - a new possibility for conservative treatment of peripheral arterial occlusion disease].
Payrits T; Ernst A; Ladits E; Pokorny H; Viragos I; Längle F
Zentralbl Chir; 2011 Oct; 136(5):431-5. PubMed ID: 22009541
[TBL] [Abstract][Full Text] [Related]
37. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
38. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski A; Schmidt HH; Sternitzky R
Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
[No Abstract] [Full Text] [Related]
40. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
